As mentioned beforehand, FGF21 could represent a helpful biomarker for NAFLD, with a reported AUROC of 0.84 for detecting NAFLD [103] and with higher diagnostic accuracy when combined with CK-18. The gene discussed is KRT18; the disease is metabolic dysfunction-associated steatotic liver disease.